Pilot Study Assessing the Feasibility of Applying Bilateral Subthalamic Nucleus Deep Brain Stimulation in Very Early Stage Parkinson's Disease: Study Design and Rationale-Reference-Cited by-同舟云学术

Pilot Study Assessing the Feasibility of Applying Bilateral Subthalamic Nucleus Deep Brain Stimulation in Very Early Stage Parkinson's Disease: Study Design and Rationale

Published:2012 Issue:3 Volume:2 Page:215-223
ISSN:1877-718X
Container-title:Journal of Parkinson's Disease
language:
Short-container-title:

Author:

Charles David¹,Tolleson Christopher¹,Davis Thomas L.¹,Gill Chandler E.²,Molinari Anna L.¹,Bliton Mark J.³,Tramontana Michael G.⁴,Salomon Ronald M.⁴,Kao Chris⁵,Wang Lily⁶,Hedera Peter¹,Phibbs Fenna T.¹,Neimat Joseph S.⁵,Konrad Peter E.⁵

Affiliation:

1. Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA

2. Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA

3. Center for Biomedical Ethics, Vanderbilt University Medical Center, Nashville, TN, USA

4. Department of Psychology, Vanderbilt University Medical Center, Nashville, TN, USA

5. Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA

6. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Clinical Neurology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Connectivity Profile for Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson Disease;Annals of Neurology;2023-06-05

2. Eleven-Year Outcomes of Deep Brain Stimulation in Early-Stage Parkinson Disease;Neuromodulation: Technology at the Neural Interface;2023-02

3. Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medication costs;Clinical Neurology and Neurosurgery;2021-11

4. Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update;Pharmaceuticals;2021-07-25

5. Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders;International Journal of Molecular Sciences;2021-02-05